Preclinical evaluation of novel triphenylphosphonium salts with broad-spectrum activity
about
From broad-spectrum biocides to quorum sensing disruptors and mussel repellents: antifouling profile of alkyl triphenylphosphonium saltsStructural basis for the inhibition of HSP70 and DnaK chaperones by small-molecule targeting of a C-terminal allosteric pocketMechanistic evaluation of a novel small molecule targeting mitochondria in pancreatic cancer cellsMitochondria-targeted vitamin E analogs inhibit breast cancer cell energy metabolism and promote cell death.Phosphonium lipocations as antiparasitic agentsMitochondria-targeted nitroxide, Mito-CP, suppresses medullary thyroid carcinoma cell survival in vitro and in vivo.Selective Inhibition of the Mitochondrial Permeability Transition Pore Protects against Neurodegeneration in Experimental Multiple SclerosisMitochondria-targeted drugs synergize with 2-deoxyglucose to trigger breast cancer cell death.Mitochondria-Targeted Analogues of Metformin Exhibit Enhanced Antiproliferative and Radiosensitizing Effects in Pancreatic Cancer CellsTargeting mitochondrial function for the treatment of breast cancer.Triphenylarsonium-functionalised gold nanoparticles: potential nanocarriers for intracellular therapeutics.Design, synthesis and biological evaluation of mitochondria targeting theranostic agents.Suppression of B-RafV600E melanoma cell survival by targeting mitochondria using triphenyl-phosphonium-conjugated nitroxide or ubiquinone.Mitochondrial-targeted nitroxides disrupt mitochondrial architecture and inhibit expression of peroxiredoxin 3 and FOXM1 in malignant mesothelioma cells.Design and synthesis of 3-carbamoylbenzoic acid derivatives as inhibitors of human apurinic/apyrimidinic endonuclease 1 (APE1).Mitochondria-Targeted Triphenylphosphonium-Based Compounds: Syntheses, Mechanisms of Action, and Therapeutic and Diagnostic Applications.Mitochondrially targeted compounds and their impact on cellular bioenergetics.A review of the basics of mitochondrial bioenergetics, metabolism, and related signaling pathways in cancer cells: Therapeutic targeting of tumor mitochondria with lipophilic cationic compounds.Mitochondria-targeted cancer therapy using a light-up probe with aggregation-induced-emission characteristics.QSAR studies and antimicrobial potential of 1,3-thiazolylphosphonium salts.Targeting tumor glycolysis by a mitotropic agent.Exosomes in colorectal carcinoma formation: ALIX under the magnifying glass.Mitochondrial Delivery of Phenol Substructure Triggers Mitochondrial Depolarization and Apoptosis of Cancer Cells.
P2860
Q27309452-ADF1287F-0A14-41A8-A551-5A1BD9B9E15AQ28246523-F2783D1F-C6CF-4D87-A69C-BE659ED49ECEQ28485201-59D6E86F-2467-4E63-914D-A2E30D101E9DQ34771531-5F0BA432-BD95-4214-87D2-07669E639214Q35874776-3642E112-0281-4EDA-B1AC-128FB3448DBBQ36736460-1F812A26-FE60-4E2A-A9A3-205DCEB4CCE3Q36744474-90A925F6-E904-4391-924E-D636F9073D7AQ36979129-6E3B9099-D8F8-4EAD-9EF9-2BD065EFF76EQ37059785-3851B809-7121-46E8-8893-3A152920526FQ38264534-801C8577-5B19-4D75-B904-7E2E0F6406ABQ38910872-3321174D-DD00-47B6-A6A4-805F70742BDDQ38979877-17578E41-50D7-4D54-BAE4-2D8502C4BCE3Q39244587-D235B0C8-B395-41FA-A325-DEB72211A382Q39270199-CCB17E3B-16A4-43C6-B926-FB532653A778Q39284845-CEDCC92F-5EAC-405A-96EF-879B15FA9D27Q39400621-23324CDE-F652-444F-9A62-E762FBAA404EQ40513041-F4D89458-5C73-4134-AD54-99F4569BC7F0Q42269519-626F1468-A68A-4124-91D7-338BDB6AFAB1Q42834435-922FF71B-2789-4A54-8E4C-FE39A31F5DEBQ49858798-0CF29539-0DAC-4E66-842B-C2A2F9649AC9Q50929846-2FEF7B27-C4CF-4BB8-9374-A7AFB8E330A9Q52871138-B0DC6BE3-AD66-4B33-AF14-216B8D6C5B18Q55306658-17F745B3-5E25-45B2-880C-DE8A8DD77ABE
P2860
Preclinical evaluation of novel triphenylphosphonium salts with broad-spectrum activity
description
2010 nî lūn-bûn
@nan
2010 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Preclinical evaluation of novel triphenylphosphonium salts with broad-spectrum activity
@ast
Preclinical evaluation of novel triphenylphosphonium salts with broad-spectrum activity
@en
Preclinical evaluation of novel triphenylphosphonium salts with broad-spectrum activity
@nl
type
label
Preclinical evaluation of novel triphenylphosphonium salts with broad-spectrum activity
@ast
Preclinical evaluation of novel triphenylphosphonium salts with broad-spectrum activity
@en
Preclinical evaluation of novel triphenylphosphonium salts with broad-spectrum activity
@nl
prefLabel
Preclinical evaluation of novel triphenylphosphonium salts with broad-spectrum activity
@ast
Preclinical evaluation of novel triphenylphosphonium salts with broad-spectrum activity
@en
Preclinical evaluation of novel triphenylphosphonium salts with broad-spectrum activity
@nl
P2093
P2860
P1433
P1476
Preclinical evaluation of novel triphenylphosphonium salts with broad-spectrum activity
@en
P2093
Divya Pathania
Jinxia Deng
Laleh Taheri
Melissa Millard
Nouri Neamati
Yumna Shabaik
P2860
P304
P356
10.1371/JOURNAL.PONE.0013131
P407
P577
2010-10-04T00:00:00Z